ARCHIVES

Phase II Study Finds Dasatinib May Overcome ALL Resistance

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Nine Cancer Act Changes Considered By NCAB Subcommittee

September 3, 1976

House-Senate Conferees Approve $6 Million Centers Amendment to Supplemental Appropriations Bill

June 27, 1986

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

March 26, 2010

Senate Bill Would Prohibit Political Appointments To Advisory Groups

January 9, 1976

GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It

October 22, 1982